Registration of financial instruments

With reference to an application submitted under Art. 27 (1) of Part III - Listing Rules and on the grounds of Art. 34 (3) thereof, the BSE Director of Trading has ordered the admission to trade on the Exchange Traded Products Segment of the BSE Main Market of the following issue of structured products:
- Issuer: Sopharma AD
- ISIN of the issue: BG9200001253
- BSE code assigned to the issue: SFA3W
- CFI code of the issue: RWSTBE
- Type of instrument: Dematerialised, registered and freely transferable warrants
- Amount of the issue: 8,985,800 warrants at the issue price per warrant of EUR 0.14, entitling their holders to exercise within three (3) years the warrants by subscribing to the respective number of shares of the underlying asset, which Sopharma AD is going to issue at a future capital increase, at the issue price of EUR 1.84 per share and a conversion warrant to share ratio of 1:1.
- Issuance currency: EUR
- Currency of trading: EUR
- Date of issuance: 02 March 2026
- Date of maturity: 02 March 2029
- First trading day: 01 April 2026 (Wednesday)
- Last trading day: 28 February 2029
- Segment MIC: ZBUL
- Trading lot: One lot = 1 /one/ warrant
- Minimum tick size: 0.001
- The indicative reference price set for the first trading session: EUR 0.14

INFORMATION ON THE ISSUER:
- Name in the Latin alphabet: Sopharma AD
- Seat of business: Sofia, 16 Iliensko shose St.
- UIC: 831902088
- LEI code: 097900BGGW0000048796
- Correspondence address: Sofia, 16 Iliensko shose St.
- Tel.: +359 2 4055 319
- E-mail: ir@sopharma.bg
- Website: www.sopharma.bg
- Authorised representative: Ognyan Donev
- Investor Relations Director: Pelagiya Viyacheva
- Information disclosure media: www.x3news.com; www.investor.bg
- Scope of business activity (Class under NACE Rev. 2.1): 21.20 - Manufacture of pharmaceutical preparations.